These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18540488)

  • 1. Oral anticoagulants vs. antiplatelet therapy.
    Hitzeman N; Applebaum S
    Am Fam Physician; 2008 May; 77(9):1250-2. PubMed ID: 18540488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?].
    MMW Fortschr Med; 2006 Sep; 148(38):14. PubMed ID: 17036954
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
    Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
    Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet properties of oral anticoagulants.
    Frère C; Laine M; Paganelli F; Dignat-George F; Bonello L
    Int J Cardiol; 2015 Feb; 181():413-4. PubMed ID: 25555288
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation in elderly patients with dementia.
    Formiga F; Fort I; Reig L; Robles MJ; Espinosa MC; Rodriguez D
    Gerontology; 2009; 55(2):202-4. PubMed ID: 18787322
    [No Abstract]   [Full Text] [Related]  

  • 8. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of anticoagulant and anti-platelet therapy in patients with atrial fibrillation: a comment on the recent ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation.
    Rubboli A; Di Pasquale G
    Eur Heart J; 2006 Dec; 27(23):2908-9; author reply 2909-10. PubMed ID: 17074773
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
    Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL;
    Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease.
    Cid AR; Zorio E; Haya S; Zúñiga P; Rueda J; Casaña P; Cabrera N; Arnau MA; Aznar JA
    Haemophilia; 2007 Nov; 13(6):760-2. PubMed ID: 17973853
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulants and antiplatelet drugs.
    Gallus AS
    Med J Aust; 1994 Jan; 160(2):78-82. PubMed ID: 8309373
    [No Abstract]   [Full Text] [Related]  

  • 15. Viewpoint: a proposal for a simple algorithm for managing oral anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation and coronary stents.
    Steg PG; Bhatt DL
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):93-97. PubMed ID: 26463061
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 17. Concomitant antiplatelet and anticoagulation therapy: indications, controversies and practical advice.
    Dowd M
    Thromb Res; 2008; 123 Suppl 1():S11-5. PubMed ID: 18822448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.
    Lip GY; Watson T
    Eur Heart J; 2007 Apr; 28(8):926-8. PubMed ID: 17430998
    [No Abstract]   [Full Text] [Related]  

  • 19. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can the risk of atrial fibrillation due to pulmonary embolism be minimized by addition of a platelet aggregation inhibitor to an oral anticoagulant?].
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1784. PubMed ID: 1407130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.